Organisation paid for research Program year 2025 Source: CMS Open Payments

A1 Clinical Network LLC

Neither a doctor nor a teaching hospital

Research payments

$260,186

62 payments

Through program year 2025, A1 Clinical Network LLC is reported as receiving $260,186 in research payments, across 62 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$83,767	30
2024	Research	$65,105	14
2023	Research	$50,837	7
2022	Research	$10,750	2
2021	Research	$48,912	8
2020	Research	$815	1

Breakdown

Who paid Research payments · program years 2020–2025

Genentech, Inc. $150,699 21 payments
Janssen Research & Development, LLC $39,120 2 payments
Teva Pharmaceuticals USA, Inc. $19,470 26 payments
Hoffmann-La Roche Limited $18,856 9 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $18,600 1 payment
Aurinia Pharma U.S., Inc. $10,000 1 payment
F. Hoffmann-La Roche AG $2,691 1 payment
GlaxoSmithKline, LLC. $750 1 payment

Studies the money was for Research payments · program years 2020–2025

Roche Cancer Screening Collection Study $76,396 11 payments
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis (Ametrine-2) $42,235 6 payments
A Phase 2 Multi Center Randomized Double blind Placebo controlled Platform Study Evaluating the Efficacy and Safety of Interventions in Participants with Moderately to Severely Active Crohn's Disease $39,120 2 payments
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) $34,759 5 payments
Tv50717-Cns-40223 $19,470 26 payments
Taar1 4 for Negative Symptoms $18,856 9 payments
Connex-2 $18,600 1 payment
A Randomized, Controlled Double-Blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 MG Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis $10,000 1 payment
A 52-Week, Randomised, Double-Blind, Double-Dummy, Parallel Group, Mul $750 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.